MERCK (NYSE: MRK), known as MSD (www.MSD.com) outside the United States and Canada, today announced that ERVEBO [Ebola Zaire Vaccine (rVSVΔ-ZEBOV-GP live)] has been awarded prequalification status by the World Health Organization (WHO).
Tropical diseases
Novartis announces new strategy to provide innovative medicines to more patients in sub-Saharan Africa
Novartis announced today a new strategy to broaden patient reach and availability of its portfolio of medicines in sub-Saharan Africa (SSA), which is home to the largest underserved patient population in the world.
Graphene shield shows promise in blocking mosquito bites
An innovative graphene-based film helps shield people from disease-carrying mosquitos, according to a new study funded by the National
